Merck KGaA (ETR:MRK)
105.05
-1.85 (-1.73%)
At close: Mar 27, 2026
Merck KGaA Revenue
In the year 2025, Merck KGaA had annual revenue of 21.10B EUR, down -0.26%. Merck KGaA had revenue of 5.25B in the quarter ending December 31, 2025, a decrease of -3.11%.
Revenue
21.10B
Revenue Growth
-0.25%
P/S Ratio
2.16
Revenue / Employee
357.19K
Employees
59,077
Market Cap
45.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 21.10B | -54.00M | -0.26% |
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | 16.15B | 1.32B | 8.87% |
| Dec 31, 2018 | 14.84B | 319.00M | 2.20% |
| Dec 31, 2017 | 14.52B | -507.00M | -3.37% |
| Dec 31, 2016 | 15.02B | 2.18B | 16.96% |
| Dec 31, 2015 | 12.85B | 1.48B | 13.04% |
| Dec 31, 2014 | 11.36B | 267.70M | 2.41% |
| Dec 31, 2013 | 11.10B | -77.80M | -0.70% |
| Dec 31, 2012 | 11.17B | 896.50M | 8.72% |
| Dec 31, 2011 | 10.28B | 985.80M | 10.61% |
| Dec 31, 2010 | 9.29B | 1.54B | 19.93% |
| Dec 31, 2009 | 7.75B | 157.40M | 2.07% |
| Dec 31, 2008 | 7.59B | 532.50M | 7.55% |
| Dec 31, 2007 | 7.06B | 2.60B | 58.25% |
| Dec 31, 2006 | 4.46B | -1.41B | -24.03% |
| Dec 31, 2005 | 5.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Fresenius Medical Care AG | 19.63B |
| Sartorius Aktiengesellschaft | 3.54B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |
| Ottobock SE & Co. KGaA | 1.68B |
Merck KGaA News
- 11 days ago - TrumpRx lists many medicines at prices higher than paid in UK - Reuters
- 24 days ago - Merck KGaA (MKKGY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Merck KGaA (MKKGY) Q4 2025 Press Conference Call Transcript - Seeking Alpha
- 24 days ago - Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings - WSJ
- 24 days ago - Merck KGaA sees earnings decline of up to 4% - Reuters
- 2 months ago - Merck KGaA (MKKGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 months ago - Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case - WSJ
- 4 months ago - Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters